Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/11958
Registo completo
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | Brekke, Kurt R. | - |
dc.contributor.author | Holmås, Tor Helge | - |
dc.contributor.author | Straume, Odd Rune | - |
dc.date.accessioned | 2011-03-24T17:27:52Z | - |
dc.date.available | 2011-03-24T17:27:52Z | - |
dc.date.issued | 2011-03 | - |
dc.identifier.citation | "Journal of Public Economics". ISSN 0047-2727. | por |
dc.identifier.issn | 0047-2727 | por |
dc.identifier.uri | https://hdl.handle.net/1822/11958 | - |
dc.description.abstract | We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on prices and market shares of brand-names and generics. Then, we exploit a detailed panel data set at product level covering several off-patent molecules before and after the policy reform. Off-patent drugs not subject to RP serve as our control group. We find that RP significantly reduces both brand-name and generic prices, and results in significantly lower brand-name market shares. Finally, we show that RP has a strong negative effect on average molecule prices, suggesting significant cost-savings, and that patients’ copayments decrease despite the extra surcharges under RP. | por |
dc.description.sponsorship | Fundação para a Ciência e a Tecnologia (FCT) | por |
dc.language.iso | eng | por |
dc.publisher | Elsevier 1 | por |
dc.rights | openAccess | por |
dc.subject | Pharmaceuticals | por |
dc.subject | Regulation | por |
dc.subject | Generic competition | por |
dc.title | Reference pricing, competition, and pharmaceutical expenditures : theory and evidence from a natural experiment | por |
dc.type | article | por |
dc.peerreviewed | yes | por |
sdum.publicationstatus | in publication | por |
oaire.citationStartPage | 624 | por |
oaire.citationEndPage | 638 | por |
oaire.citationIssue | 7-8 | por |
oaire.citationTitle | Journal of Public Economics | por |
oaire.citationVolume | 95 | por |
dc.identifier.doi | 10.1016/j.jpubeco.2010.11.015 | por |
dc.subject.wos | Social Sciences | por |
sdum.journal | Journal of Public Economics | por |
Aparece nas coleções: | NIPE - Artigos em Revistas de Circulação Internacional com Arbitragem Científica |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
RP_merged.pdf | Reference pricing, competition, and pharmaceutical expenditures | 292,03 kB | Adobe PDF | Ver/Abrir |